Please login to the form below

Not currently logged in
Email:
Password:

Lilly hires new ACE president

Eli Lilly & Company veteran, Andrew Hotchkiss, is to become the company's president for the Australia, Canada and Europe (ACE) region

Eli Lilly & Company veteran, Andrew Hotchkiss, is to become the company's president for the Australia, Canada and Europe (ACE) region.

Hotchkiss takes over from Karim Bitar, and will lead company activities across the region, as Lilly seeks to deliver innovative developments tackling illnesses such as diabetes, heart disease, mental health and cancer. 

Andrew Hotchkiss
Andrew Hotchkiss

Hotchkiss was most recently vice president and international business unit leader for Lilly Oncology.

"I am proud and excited to have the opportunity to lead Lilly's hugely talented pool of dedicated employees across the region, who are focused on the mission to help improve outcomes for patients," said Hotchkiss.

Bryce Carmine, executive vice president and president, Lilly Bio-Medicines, also commented on the appointment: "[Hotchkiss] will be a tremendous asset to the organisation in leading our efforts to maximise the value of our marketed products and prepare Lilly's ACE region for the next wave of innovative Lilly medicines."

9th June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics